Stock listing
RI2 Stock Price, News, Filings & Events — Rigel Pharmaceuticals, Inc.
Selected listing: RI2 · GETTEX · EUR · DE
This page tracks Rigel Pharmaceuticals, Inc.'s RI2:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following RI2:GETTEX. RI2:GETTEX is the stock-level entry point for investors researching Rigel Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Rigel Pharmaceuticals, Inc. (Ticker: RIGL) is a public company based in America, with a market capitalization of approximately $680 million. The company focuses on the development of innovative therapies for various diseases. Rigel is dedicated to advancing its pipeline of drug candidates to address unmet medical needs.
- Ticker
- RI2:GETTEX
- Asset type
- Stock
- Market cap
- $868.2M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- GETTEX
- Currency
- EUR
Rigel Pharmaceuticals, Inc. RI2:GETTEX stock context
This page tracks Rigel Pharmaceuticals, Inc.'s RI2:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following RI2:GETTEX. RI2:GETTEX is the stock-level entry point for investors researching Rigel Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Rigel Pharmaceuticals, Inc. (Ticker: RIGL) is a public company based in America, with a market capitalization of approximately $680 million. The company focuses on the development of innovative therapies for various diseases. Rigel is dedicated to advancing its pipeline of drug candidates to address unmet medical needs.
Latest news from Rigel Pharmaceuticals, Inc.
Rigel Announces Availability of VEPPANU™ (vepdegestrant) for Patients with ER+/HER2-, ESR1-Mutated Advanced or Metastatic Breast Cancer
August 13, 2026
Rigel Reports Second Quarter 2026 Financial Results
August 4, 2026
Onco360® Has Been Selected as a National Pharmacy Partner for VEPPANU™ (vepdegestrant)
July 29, 2026
Rigel Announces Conference Call and Webcast to Report Second Quarter 2026 Financial Results
July 28, 2026
Rigel Announces Closing of Licensing Agreement for VEPPANU™ (vepdegestrant)
June 16, 2026
Rigel Pharmaceuticals, Inc. earnings calls
Rigel Pharmaceuticals, Inc. (RIGL) Q2 2026 Earnings Call
August 4, 2026 · Replay with transcript and chapters
Rigel Pharmaceuticals, Inc. (RIGL) Q1 2026 Earnings Call
May 5, 2026 · Replay with transcript and chapters
Rigel Pharmaceuticals, Inc. (RIGL) Q4 2025 Earnings Call
March 3, 2026 · Replay with transcript and chapters
Rigel Pharmaceuticals, Inc. (RIGL) Q3 2025 Earnings Call
November 4, 2025 · Replay with transcript and chapters
Rigel Pharmaceuticals, Inc. (RIGL) Q2 2025 Earnings Call
August 5, 2025 · Replay with transcript and chapters
Rigel Pharmaceuticals, Inc. (RIGL) Q1 2025 Earnings Call
May 6, 2025 · Replay with transcript and chapters
Research Rigel Pharmaceuticals, Inc.
Rigel Pharmaceuticals, Inc. investor report
Review AI stock analysis and investor report context for RI2:GETTEX.
Rigel Pharmaceuticals, Inc. company profile
View the public company page for Rigel Pharmaceuticals, Inc. on 6ix.
Rigel Pharmaceuticals, Inc. news
Read company news and market updates connected to Rigel Pharmaceuticals, Inc..
Rigel Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Rigel Pharmaceuticals, Inc..
Alternate listings
RIGL:NASDAQ
US · USD
Alternate listing for Rigel Pharmaceuticals, Inc.; the primary context on this page is RI2:GETTEX.
A40EFY:LSX
DE · EUR
Alternate listing for Rigel Pharmaceuticals, Inc.; the primary context on this page is RI2:GETTEX.
A40EFY:LS
DE · EUR
Alternate listing for Rigel Pharmaceuticals, Inc.; the primary context on this page is RI2:GETTEX.
RI2:TRADEGATE
DE · EUR
Alternate listing for Rigel Pharmaceuticals, Inc.; the primary context on this page is RI2:GETTEX.
RIGL:BX
CH · CHF
Alternate listing for Rigel Pharmaceuticals, Inc.; the primary context on this page is RI2:GETTEX.
RIGL:BOATS
US · USD
Alternate listing for Rigel Pharmaceuticals, Inc.; the primary context on this page is RI2:GETTEX.
RI2:DUS
DE · EUR
Alternate listing for Rigel Pharmaceuticals, Inc.; the primary context on this page is RI2:GETTEX.
RI2:FWB
DE · EUR
Alternate listing for Rigel Pharmaceuticals, Inc.; the primary context on this page is RI2:GETTEX.
RI2:MUN
DE · EUR
Alternate listing for Rigel Pharmaceuticals, Inc.; the primary context on this page is RI2:GETTEX.
RI2:SWB
DE · EUR
Alternate listing for Rigel Pharmaceuticals, Inc.; the primary context on this page is RI2:GETTEX.